Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival (Q33622587)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival |
scientific article |
Statements
1 reference
Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival (English)
1 reference
Ursula Matulonis
1 reference
Adam Clauss
1 reference
Vivian Ng
1 reference
Joyce Liu
1 reference
Huiying Piao
1 reference
Moises Russo
1 reference
Natalie Vena
1 reference
Qing Sheng
1 reference
Michelle S Hirsch
1 reference
Tomas Bonome
1 reference
Azra H Ligon
1 reference
Michael J Birrer
1 reference
Ronny Drapkin
1 reference
1 February 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference